DBV says Phase 3 Trial of Viaskin Peanut in Toddlers Met Pri

(PLX AI) - DBV Technologies Announces Positive Topline Results from Phase 3 EPITOPE Trial of Viaskin Peanut in Peanut-Allergic Toddlers.• DBV Technologies says 67.0% of subjects treated with Viaskin Peanut

Related Keywords

Kostenloser Wertpapierhandel , , Announces Positive Topline Results , Viaskin Peanut , Says , Hase , Trial , Viaskin , Peanut , Toddlers , Primary , Ndpoint ,